I think you&#x27;re being disingenuous for the sake of argument. There is a non-trivial scientific challenge of characterizing both proinsulin subunits and developing a protocol that works for public domain without adverse effects. Specifically, getting the sequence right to get the folding right.<p>Yeah, it&#x27;s been done before but with different variations. To do so in a way that isn&#x27;t locked up in IP is worthwhile. And it&#x27;s a challenge that faces an uphill battle in terms of incentive and payoff. The crowdfunding covers that risk capital gap that would otherwise make this impossible. You could say their approach is a road not taken.